Pediatr Blood Cancer
Dr. Kara-Marie Hack Delaney, MD
- Publications
- 4
- Clinical trials
- 3
- Industry payments
- $40
- Medical group
- 1
- State license
- 1
- Practice address
- 7850 S Hardy Dr, Tempe, AZ 85284
- Practice phone
- Call (808) 489-9384
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Option Care
Tempe, Arizona
Find Dr. Delaney's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kara-Marie Hack Delaney is a pediatric hematology and oncology physician in Tempe, Arizona
Dr. Delaney practices at Option Care in Tempe, Arizona.
Dr. Delaney's NPI, 1568548907, was assigned on October 28, 2006. Dr. Delaney holds California license A 96877.
- NPI
- 1568548907NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8325510449
- NPI enumeration date
- October 28, 2006
- NPI status
- Active
- Practice phone
- (808) 489-9384
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Kara-Marie Hack Delaney practices at Option Care in Tempe, Arizona
Dr. Delaney's primary practice is Option Care, at 7850 S Hardy Dr, Tempe, AZ 85284 in Maricopa County. The practice phone is (808) 489-9384.
- Option Care7850 S Hardy Dr, Tempe, AZ 85284 · Maricopa CountyPhone(808) 489-9384
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Kara-Marie Hack Delaney is affiliated with 1 site of care and 1 medical group
Dr. Delaney's primary practice is Option Care in Tempe, Arizona. The medical group on file is Navian Hawaii.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Kara-Marie Hack Delaney's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delaney practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Option Care | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kara-Marie Hack Delaney is one of 56 pediatric hematologys and oncology physicians in Arizona
Pediatric hematology-oncology is Dr. Delaney's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Delaney is licensed in California.
Specialties and state licenses
- Pediatric hematology and oncology, CaliforniaPrimary
Pediatric hematologys and oncology physicians near Dr. Delaney
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kara-Marie Hack Delaney has 4 publications on record
Dmand AI links 4 papers to Dr. Delaney, published from 2013 to 2018. 2013 was the busiest year, with 2. Dr. Delaney's most frequent co-authors are Gregory James Kato, MD, Caterina P. Minniti, MD and Patricia E. Adams-Graves, MD.
Dr. Delaney's most frequent co-authors
- Gregory James Kato, MD3 shared papers
- Caterina P. Minniti, MD3 shared papers
- Patricia E. Adams-Graves, MD1 shared paper
Recent publications by Dr. Delaney
See who Dr. Delaney researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Delaney works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kara-Marie Hack Delaney has worked on 3 clinical trials
Dmand AI links Dr. Delaney to 3 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Embryonal, Ganglioneuroblastoma and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Children's Oncology Group sponsors the most, 2.
Conditions in Dr. Delaney's trials
- Carcinoma, Embryonal
- Ganglioneuroblastoma
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Down Syndrome
- Endodermal Sinus Tumor
Investigators on the most trials with Dr. Delaney
- Teena Bhatla, MD2 shared trials
- Meghen B. Browning, MD2 shared trials
- Mahmut Yasar Celiker, MD2 shared trials
Recent clinical trials with Dr. Delaney
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia (opens in a new tab)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors (opens in a new tab)
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kara-Marie Hack Delaney received $40 in industry payments from 2021 to 2024
CMS Open Payments shows 2 general payments to Dr. Delaney from 2 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $22.
General payments to Dr. Delaney by program year, 2021 to 2024
Companies that paid Dr. Delaney the most, 2021 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kara-Marie Hack Delaney's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kara-Marie Hack Delaney
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kara-Marie Hack Delaney's NPI number?
Dr. Kara-Marie Hack Delaney's NPI number is 1568548907. It was assigned on October 28, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kara-Marie Hack Delaney?
Dr. Kara-Marie Hack Delaney is a pediatric hematology and oncology physician in Tempe, Arizona. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Kara-Marie Hack Delaney practice?
Dr. Delaney practices at 7850 S Hardy Dr, Tempe, AZ 85284. Dr. Delaney's primary practice is Option Care in Tempe, Arizona.
What is Dr. Kara-Marie Hack Delaney's office phone number?
The practice phone on file for Dr. Delaney is (808) 489-9384.
What is Dr. Kara-Marie Hack Delaney's medical license number?
Dr. Delaney holds California license A 96877.
What medical group is Dr. Kara-Marie Hack Delaney part of?
Dr. Delaney is linked to Navian Hawaii.
Has Dr. Kara-Marie Hack Delaney received payments from drug or device companies?
CMS Open Payments shows $40 in general payments to Dr. Delaney from 2 companies from 2021 to 2024. The largest total came from Takeda Pharmaceuticals U.S.A., Inc.
How long has Dr. Kara-Marie Hack Delaney been practicing?
Dr. Delaney's NPI was assigned in 2006.
Does Dr. Kara-Marie Hack Delaney do research?
Dmand AI links 4 publications to Dr. Delaney, published from 2013 to 2018. Dr. Delaney has worked on 3 clinical trials.
Who does Dr. Kara-Marie Hack Delaney publish with?
Dr. Delaney's most frequent co-authors are Gregory James Kato, MD (3 shared papers), Caterina P. Minniti, MD (3 shared papers) and Patricia E. Adams-Graves, MD (1 shared paper).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Arizona by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card